<b>Methods:</b> Longitudinal immune profiling was performed in 18 patients with non-Hodgkin lymphoma, including 14 with relapsed/refractory diffuse large B-cell lymphoma treated with anti-CD19 CAR-T cells. The gene discussed is CD19; the disease is diffuse large B-cell lymphoma.